Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study

Detalles Bibliográficos
Autores principales: Xu, Dan, Yang, Ying, Yin, Zhao, Tu, Sanfang, Nie, Danian, Li, Yiqing, Huang, Zhenqian, Sun, Qixin, Huang, Changfen, Nie, Xiaqi, Yao, Zurong, Shi, Pengcheng, Zhang, Yu, Jiang, Xuejie, Liu, Qifa, Yu, Guopan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643486/
https://www.ncbi.nlm.nih.gov/pubmed/37957175
http://dx.doi.org/10.1038/s41408-023-00941-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643486/
https://www.ncbi.nlm.nih.gov/pubmed/37957175
http://dx.doi.org/10.1038/s41408-023-00941-4

Ejemplares similares